180 related articles for article (PubMed ID: 30504643)
21. Kluyvera urinary tract infection: case report and review of the literature.
Narchi H
Pediatr Infect Dis J; 2005 Jun; 24(6):570-2. PubMed ID: 15933577
[TBL] [Abstract][Full Text] [Related]
22. Primary and Secondary Bacteremia Caused by
Kwiecińska-Piróg J; Skowron K; Gospodarek-Komkowska E
Pol J Microbiol; 2018; 67(4):471-478. PubMed ID: 30550233
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for microbiologic failure in children with Enterobacter species bacteremia.
Boguniewicz J; Revell PA; Scheurer ME; Hulten KG; Palazzi DL
PLoS One; 2021; 16(10):e0258114. PubMed ID: 34618858
[TBL] [Abstract][Full Text] [Related]
24. Treatment options and clinical outcomes for carbapenem-resistant Enterobacteriaceae bloodstream infection in a Chinese university hospital.
Li C; Li Y; Zhao Z; Liu Q; Li B
J Infect Public Health; 2019; 12(1):26-31. PubMed ID: 30145151
[TBL] [Abstract][Full Text] [Related]
25. [Nosocomial Stenotrophomonas maltophilia infections in a university hospital].
Caylan R; Yilmaz G; Sucu N; Bayraktar O; Aydin K; Kaklikkaya N; Aydin F; Köksal I
Mikrobiyol Bul; 2005 Jan; 39(1):25-33. PubMed ID: 15900834
[TBL] [Abstract][Full Text] [Related]
26. Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study.
Mehl A; Åsvold BO; Kümmel A; Lydersen S; Paulsen J; Haugan I; Solligård E; Damås JK; Harthug S; Edna TH
BMC Infect Dis; 2017 Feb; 17(1):116. PubMed ID: 28148226
[TBL] [Abstract][Full Text] [Related]
27. Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections.
Qureshi ZA; Paterson DL; Pakstis DL; Adams-Haduch JM; Sandkovsky G; Sordillo E; Polsky B; Peleg AY; Bhussar MK; Doi Y
Int J Antimicrob Agents; 2011 Jan; 37(1):26-32. PubMed ID: 21075605
[TBL] [Abstract][Full Text] [Related]
28. Assessing antimicrobial stewardship initiatives: Clinical evaluation of cefepime or piperacillin/tazobactam in patients with bloodstream infections secondary to AmpC-producing organisms.
McKamey L; Venugopalan V; Cherabuddi K; Borgert S; Voils S; Shah K; Klinker KP
Int J Antimicrob Agents; 2018 Nov; 52(5):719-723. PubMed ID: 30125680
[TBL] [Abstract][Full Text] [Related]
29. Febrile urinary-tract infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: A French prospective multicenter study.
Madhi F; Jung C; Timsit S; Levy C; Biscardi S; Lorrot M; Grimprel E; Hees L; Craiu I; Galerne A; Dubos F; Cixous E; Hentgen V; Béchet S; ; Bonacorsi S; Cohen R
PLoS One; 2018; 13(1):e0190910. PubMed ID: 29370234
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
Zhang H; Yang Q; Liao K; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Hu Z; Chu Y; Chen S; Cao B; Su J; Gui B; Duan Q; Zhang S; Shao H; Kong H; Badal RE; Xu Y
Antimicrob Agents Chemother; 2016 Jan; 60(1):245-51. PubMed ID: 26482308
[TBL] [Abstract][Full Text] [Related]
31. [Kluyvera bacteriemia: an epidemic in a Moroccan teaching hospital].
Bellaoui N; Belabbes H; Lahsoune M; El Mdagrhri N
Med Mal Infect; 2009 Feb; 39(2):133-5. PubMed ID: 19010629
[TBL] [Abstract][Full Text] [Related]
32. The first case of third-generation cephalosporins resistant
Mutoh Y; Kobe T; Hirano T; Ichihara T; Takenaka H; Niinomi T; Umemura T; Kuroiwa M
IDCases; 2019; 15():e00498. PubMed ID: 30775241
[TBL] [Abstract][Full Text] [Related]
33. Departmental consumption of antibiotic drugs and subsequent resistance: a quantitative link.
Leibovici L; Berger R; Gruenewald T; Yahav J; Yehezkelli Y; Milo G; Paul M; Samra Z; Pitlik SD
J Antimicrob Chemother; 2001 Oct; 48(4):535-40. PubMed ID: 11581233
[TBL] [Abstract][Full Text] [Related]
34. Kluyvera ascorbata sepsis in an extremely low birth weight infant.
Sharma D; Dasi T; Murki S; Oleti TP
Indian J Med Microbiol; 2015; 33(3):437-9. PubMed ID: 26068354
[TBL] [Abstract][Full Text] [Related]
35. Non-carbapenem therapy of urinary tract infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae.
de La Blanchardière A; Dargère S; Guérin F; Daurel C; Saint-Lorant G; Verdon R; Cattoir V
Med Mal Infect; 2015 May; 45(5):169-72. PubMed ID: 25845927
[TBL] [Abstract][Full Text] [Related]
36. [The etiology of urinary tract infections and antimicrobial susceptibility: study based on children hospitalized in 2012].
Jackowska T; Chwiećko J; Hartmann P
Dev Period Med; 2014; 18(4):470-6. PubMed ID: 25874786
[TBL] [Abstract][Full Text] [Related]
37. Isolation of a zoonotic pathogen Kluyvera ascorbata from Egyptian fruit-bat Rousettus aegyptiacus.
Han JE; Gomez DK; Kim JH; Choresca CH; Shin SP; Park SC
J Vet Med Sci; 2010 Jan; 72(1):85-7. PubMed ID: 19915337
[TBL] [Abstract][Full Text] [Related]
38. Antibiotic susceptibility profiles of uncommon bacterial species causing severe infections in Italy.
Nicolosi D; Nicolosi VM; Cappellani A; Nicoletti G; Blandino G
J Chemother; 2009 Jun; 21(3):253-60. PubMed ID: 19567344
[TBL] [Abstract][Full Text] [Related]
39. Bacteremic and non-bacteremic febrile urinary tract infection--a review of 168 hospital-treated patients.
Jerkeman M; Braconier JH
Infection; 1992; 20(3):143-5. PubMed ID: 1644489
[TBL] [Abstract][Full Text] [Related]
40. Kluyvera infections in the pediatric population.
Carter JE; Laurini JA; Mizell KN
Pediatr Infect Dis J; 2008 Sep; 27(9):839-41. PubMed ID: 18645547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
